| Trial ID: | L4200 |
| Source ID: | NCT00417716
|
| Associated Drug: |
Intravitreal Bevacizumab
|
| Title: |
Use of Intravitreal Bevacizumab in Patients With Diffuse Diabetic Macular Edema
|
| Acronym: |
|
| Status: |
WITHDRAWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus Type 2|Diabetic Macular Edema
|
| Interventions: |
DRUG: Intravitreal Bevacizumab
|
| Outcome Measures: |
Primary: BCVA|Fluorescein Angiography|Optical Coherence Tomography |
|
| Sponsor/Collaborators: |
Sponsor: Asociación para Evitar la Ceguera en México
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE3
|
| Enrollment: |
0
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2005-09
|
| Completion Date: |
2006-05
|
| Results First Posted: |
|
| Last Update Posted: |
2024-06-03
|
| Locations: |
Asociación para Evitar la Ceguera en México, Mexico city, Distrito Federal, 04030, Mexico
|
| URL: |
https://clinicaltrials.gov/show/NCT00417716
|
